List of Tables
    Table 1. Parkinson’s Disease Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Parkinson’s Disease Treatment Market Trends
    Table 3. Parkinson’s Disease Treatment Market Drivers
    Table 4. Parkinson’s Disease Treatment Market Challenges
    Table 5. Parkinson’s Disease Treatment Market Restraints
    Table 6. Global Parkinson’s Disease Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Parkinson’s Disease Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Parkinson’s Disease Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Parkinson’s Disease Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Parkinson’s Disease Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Parkinson’s Disease Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Parkinson’s Disease Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Parkinson’s Disease Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Parkinson’s Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Treatment as of 2021)
    Table 15. Top Players of Parkinson’s Disease Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Parkinson’s Disease Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Parkinson’s Disease Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Parkinson’s Disease Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Parkinson’s Disease Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Parkinson’s Disease Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Parkinson’s Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Parkinson’s Disease Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Parkinson’s Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Parkinson’s Disease Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Parkinson’s Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Parkinson’s Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Parkinson’s Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Teva Company Details
    Table 31. Teva Business Overview
    Table 32. Teva Parkinson’s Disease Treatment Product
    Table 33. Teva Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 34. Teva Recent Development
    Table 35. Roche Company Details
    Table 36. Roche Business Overview
    Table 37. Roche Parkinson’s Disease Treatment Product
    Table 38. Roche Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 39. Roche Recent Development
    Table 40. Prothena Company Details
    Table 41. Prothena Business Overview
    Table 42. Prothena Parkinson’s Disease Treatment Product
    Table 43. Prothena Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 44. Prothena Recent Development
    Table 45. Acorda Therapeutics Company Details
    Table 46. Acorda Therapeutics Business Overview
    Table 47. Acorda Therapeutics Parkinson’s Disease Treatment Product
    Table 48. Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 49. Acorda Therapeutics Recent Development
    Table 50. Voyager Therapeutics Company Details
    Table 51. Voyager Therapeutics Business Overview
    Table 52. Voyager Therapeutics Parkinson’s Disease Treatment Product
    Table 53. Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 54. Voyager Therapeutics Recent Development
    Table 55. Impax Pharmaceuticals Company Details
    Table 56. Impax Pharmaceuticals Business Overview
    Table 57. Impax Pharmaceuticals Parkinson’s Disease Treatment Product
    Table 58. Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 59. Impax Pharmaceuticals Recent Development
    Table 60. UCB Company Details
    Table 61. UCB Business Overview
    Table 62. UCB Parkinson’s Disease Treatment Product
    Table 63. UCB Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 64. UCB Recent Development
    Table 65. AbbVie Company Details
    Table 66. AbbVie Business Overview
    Table 67. AbbVie Parkinson’s Disease Treatment Product
    Table 68. AbbVie Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 69. AbbVie Recent Development
    Table 70. MSD Company Details
    Table 71. MSD Business Overview
    Table 72. MSD Parkinson’s Disease Treatment Product
    Table 73. MSD Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 74. MSD Recent Development
    Table 75. Orion Pharmaceuticals Company Details
    Table 76. Orion Pharmaceuticals Business Overview
    Table 77. Orion Pharmaceuticals Parkinson’s Disease Treatment Product
    Table 78. Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 79. Orion Pharmaceuticals Recent Development
    Table 80. Intec Pharma Company Details
    Table 81. Intec Pharma Business Overview
    Table 82. Intec Pharma Parkinson’s Disease Treatment Product
    Table 83. Intec Pharma Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 84. Intec Pharma Recent Development
    Table 85. NeuroDerm Company Details
    Table 86. NeuroDerm Business Overview
    Table 87. NeuroDerm Parkinson’s Disease Treatment Product
    Table 88. NeuroDerm Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 89. NeuroDerm Recent Development
    Table 90. Adamas Therapeutics Company Details
    Table 91. Adamas Therapeutics Business Overview
    Table 92. Adamas Therapeutics Parkinson’s Disease Treatment Product
    Table 93. Adamas Therapeutics Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 94. Adamas Therapeutics Recent Development
    Table 95. Acadia Company Details
    Table 96. Acadia Business Overview
    Table 97. Acadia Parkinson’s Disease Treatment Product
    Table 98. Acadia Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 99. Acadia Recent Development
    Table 100. Sunovion Company Details
    Table 101. Sunovion Business Overview
    Table 102. Sunovion Parkinson’s Disease Treatment Product
    Table 103. Sunovion Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 104. Sunovion Recent Development
    Table 105. GSK Company Details
    Table 106. GSK Business Overview
    Table 107. GSK Parkinson’s Disease Treatment Product
    Table 108. GSK Revenue in Parkinson’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 109. GSK Recent Development
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Parkinson’s Disease Treatment Product Picture
    Figure 2. Global Parkinson’s Disease Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Parkinson’s Disease Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Parkinson’s Disease Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Parkinson’s Disease Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Parkinson’s Disease Treatment Market Share in Global 2017-2028
    Figure 7. Parkinson’s Disease Treatment Report Years Considered
    Figure 8. Product Picture of Oral
    Figure 9. Product Picture of Transdermal
    Figure 10. Product Picture of Subcutaneous
    Figure 11. Product Picture of Intestinal Infusion
    Figure 12. Global Parkinson’s Disease Treatment Market Share by Type in 2022 & 2028
    Figure 13. Global Parkinson’s Disease Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Parkinson’s Disease Treatment Market Share by Type (2017-2028)
    Figure 15. United States Parkinson’s Disease Treatment Market Share by Type in 2022 & 2028
    Figure 16. United States Parkinson’s Disease Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Parkinson’s Disease Treatment Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospital Pharmacy
    Figure 19. Product Picture of Retail Pharmacy
    Figure 20. Product Picture of Online Pharmacy
    Figure 21. Global Parkinson’s Disease Treatment Market Share by Application in 2022 & 2028
    Figure 22. Global Parkinson’s Disease Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Parkinson’s Disease Treatment Market Share by Application (2017-2028)
    Figure 24. United States Parkinson’s Disease Treatment Market Share by Application in 2022 & 2028
    Figure 25. United States Parkinson’s Disease Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Parkinson’s Disease Treatment Market Share by Application (2017-2028)
    Figure 27. North America Parkinson’s Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Parkinson’s Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Parkinson’s Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Parkinson’s Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Parkinson’s Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Parkinson’s Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Teva Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 56. Roche Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 57. Prothena Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 58. Acorda Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 59. Voyager Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 60. Impax Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 61. UCB Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 62. AbbVie Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 63. MSD Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 64. Orion Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 65. Intec Pharma Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 66. NeuroDerm Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 67. Adamas Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 68. Acadia Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 69. Sunovion Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 70. GSK Revenue Growth Rate in Parkinson’s Disease Treatment Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed